Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Alcohol Use Discontinuation on Adipose Tissue Insulin Resistance Among Latino Patients With and Without Underlying Chronic Liver Disease.

Research square·2026
Same author

High mortality at safety-net hospitals for patients with cirrhosis.

Hepatology communications·2026
Same author

A new pediatric trauma center quality benchmarking metric: Center-level variability in postinjury functional impairment using the Functional Status Scale (FSS).

The journal of trauma and acute care surgery·2026
Same author

Defining the Society of Pediatric Liver Transplantation (SPLIT) research agenda: A Delphi consensus project.

Hepatology communications·2026
Same author

Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multicenter prospective cohort study.

Hepatology (Baltimore, Md.)·2025
Same author

Admission and Patients Undergoing Surgery at Risk of Patient-Directed Discharges.

JAMA surgery·2024
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Related Experiment Video

Updated: Jun 23, 2026

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
08:19

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Published on: July 12, 2022

Predicting irreversible left ventricular dysfunction after acute myocardial infarction.

Daniel R Frisch1, Evaldas Giedrimas, Satishkumar Mohanavelu

  • 1Division of Cardiology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. daniel.frisch@jefferson.edu

The American Journal of Cardiology
|May 2, 2009
PubMed
Summary
This summary is machine-generated.

Patients with ST-elevation myocardial infarction (STEMI) and low ejection fraction may have irreversible heart damage. Three key factors predict persistent low ejection fraction, identifying high-risk individuals for early intervention.

More Related Videos

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice
07:28

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice

Published on: July 2, 2018

Related Experiment Videos

Last Updated: Jun 23, 2026

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
08:19

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Published on: July 12, 2022

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice
07:28

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice

Published on: July 2, 2018

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Reduced left ventricular ejection fraction (LVEF) after myocardial infarction (MI) increases mortality risk.
  • Implantable cardioverter-defibrillators (ICDs) can mitigate mortality in high-risk patients.
  • Identifying patients with irreversible left ventricular dysfunction is crucial for timely treatment.

Purpose of the Study:

  • To identify predictors of irreversible left ventricular dysfunction in ST-elevation myocardial infarction (STEMI) patients.
  • To evaluate clinical, angiographic, and electrocardiographic characteristics associated with persistent low LVEF.
  • To determine if specific factors can predict LVEF

Main Methods:

  • Retrospective analysis of 118 STEMI patients with LVEF <=0.4 after percutaneous coronary intervention (PCI).
  • Evaluation of clinical, angiographic, and electrocardiographic data at STEMI presentation.
  • Multivariate analysis to identify predictors of LVEF <=0.3 at >=90 days.

Main Results:

  • Post-PCI LVEF <=0.3, Killip class >I, and Q waves on postrevascularization ECG predicted LVEF <=0.3 at >=90 days.
  • Odds ratios: 5.4 for LVEF <=0.3, 4.4 for Killip class >I, 6.3 for Q waves.
  • The presence of all three factors in 12% of patients had a 100% positive predictive value for persistent LVEF <=0.3.

Conclusions:

  • Post-PCI LVEF <=0.3, Killip class >I, and Q waves are significant predictors of persistent left ventricular dysfunction after STEMI.
  • A combination of these three factors identifies a high-risk group with 100% certainty of LVEF <=0.3 at 90 days.
  • This high-risk group may benefit from early, aggressive therapies, potentially including ICD implantation.